Nanoemulsion-based systems as a promising approach for enhancing the antitumoral activity of pequi oil (Caryocar brasilense Cambess.) in breast cancer cells

Previous studies have reported the effects of pequi oil (Caryocar brasiliense Cambess.) in cancer prevention and treatment. However, its biomedical applications are limited due to the hydrophobic nature of the oil. In this study, we used nanotechnology strategies to design and characterize a pequi o...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of drug delivery science and technology Vol. 58; p. 101819
Main Authors:	Ombredane, Alicia S., Araujo, Victor H.S., Borges, Clarissa O., Costa, Patrícia L., Landim, Marcela G., Pinheiro, Andréia C., Szlachetka, Ísis O., Benedito, Luiz E.C., Espindola, Laila S., Dias, Diego J.S., Oliveira, Daniela M., Chaker, Juliano A., da Silva, Sebastião W., de Azevedo, Ricardo B., Joanitti, Graziella A.
Format:	Journal Article
Language:	English
Published:	Elsevier B.V 01-08-2020
Subjects:	Breast cancer Cytotoxicity Nanoemulsion Pequi oil Stability Cytotoxicity Pequi oil Breast cancer Stability Nanoemulsion
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Previous studies have reported the effects of pequi oil (Caryocar brasiliense Cambess.) in cancer prevention and treatment. However, its biomedical applications are limited due to the hydrophobic nature of the oil. In this study, we used nanotechnology strategies to design and characterize a pequi oil-based nanoemulsion and evaluate its anticancer effects. Our data show that monodisperse (PdI 0.23) pequi oil nanoemulsions (123 nm – hydrodynamic diameter; −15 mV – zeta potential) were prepared successfully using lecithin as surfactant and had physicochemical stability when exposed to stress conditions (pH and serial dilution) or long-term (200 days) storage at different temperatures. Significant dose- and time-dependent antitumoral effects against breast cancer cells (4T1) were also observed (IC50 of 299.8 and 173.7 μg/mL after 24 and 48 h respectively, p < 0.001), along with lower cytotoxicity against non-tumoral cells (NIH/3T3) (IC50 of 442.7 and 380.3 μg/mL after 24 and 48 h respectively). In addition, we show that in our formulation, pequi oil has a dual role, behaving both as a structural component of the nanoemulsion and as a cytotoxic agent against breast cancer cells. Taken together, our results reveal pequi oil-based nanoemulsion as a promising nanosized platform to be used as an adjuvant tool for breast cancer treatments. [Display omitted] •A monodisperse nanoemulsion based on pequi oil (PeNE) was successfully obtained.•PeNE was stable under stress conditions and long-term storage.•PeNE showed significant antitumoral effects against breast cancer cells (4T1).•PeNE was less cytotoxic against non-tumoral cells (NIH/3T3) than in 4T1 cells.
ISSN:	1773-2247
DOI:	10.1016/j.jddst.2020.101819